Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 13 studies | 60% ± 26% | |
GABAergic neuron | 9 studies | 56% ± 27% | |
oligodendrocyte precursor cell | 9 studies | 41% ± 15% | |
microglial cell | 8 studies | 43% ± 13% | |
amacrine cell | 7 studies | 46% ± 20% | |
astrocyte | 7 studies | 33% ± 16% | |
interneuron | 6 studies | 63% ± 18% | |
neuron | 5 studies | 36% ± 12% | |
type II pneumocyte | 5 studies | 37% ± 8% | |
endothelial cell | 4 studies | 41% ± 22% | |
epithelial cell | 4 studies | 29% ± 14% | |
retinal ganglion cell | 4 studies | 24% ± 11% | |
GABAergic interneuron | 3 studies | 62% ± 9% | |
retina horizontal cell | 3 studies | 19% ± 3% | |
GABAergic amacrine cell | 3 studies | 41% ± 14% | |
glycinergic amacrine cell | 3 studies | 36% ± 1% | |
retinal pigment epithelial cell | 3 studies | 24% ± 3% | |
ependymal cell | 3 studies | 28% ± 14% | |
basal cell | 3 studies | 30% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 14 studies | 44% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 3925.29 | 2617 / 2642 | 81% | 2.11 | 569 / 705 |
prostate | 93% | 657.78 | 227 / 245 | 7% | 0.12 | 37 / 502 |
bladder | 90% | 819.14 | 19 / 21 | 3% | 0.08 | 16 / 504 |
esophagus | 76% | 345.91 | 1094 / 1445 | 5% | 0.10 | 10 / 183 |
blood vessel | 77% | 380.12 | 1029 / 1335 | 0% | 0 | 0 / 0 |
kidney | 69% | 283.92 | 61 / 89 | 4% | 0.11 | 38 / 901 |
thymus | 60% | 199.16 | 392 / 653 | 11% | 0.22 | 67 / 605 |
breast | 64% | 273.53 | 293 / 459 | 7% | 0.14 | 79 / 1118 |
lung | 62% | 288.15 | 357 / 578 | 6% | 0.12 | 65 / 1155 |
skin | 63% | 447.30 | 1146 / 1809 | 1% | 0.01 | 3 / 472 |
adipose | 50% | 243.57 | 600 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 44% | 130.76 | 114 / 258 | 3% | 0.04 | 6 / 230 |
stomach | 36% | 111.15 | 128 / 359 | 1% | 0.02 | 3 / 286 |
uterus | 25% | 70.56 | 43 / 170 | 2% | 0.02 | 7 / 459 |
intestine | 21% | 58.34 | 202 / 966 | 1% | 0.01 | 5 / 527 |
spleen | 20% | 52.63 | 47 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 19% | 389.99 | 179 / 929 | 0% | 0 | 0 / 0 |
ovary | 9% | 24.71 | 17 / 180 | 0% | 0.00 | 1 / 430 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.11 | 2 / 29 |
heart | 4% | 11.31 | 33 / 861 | 0% | 0 | 0 / 0 |
pancreas | 3% | 6.72 | 9 / 328 | 0% | 0 | 0 / 178 |
liver | 0% | 0 | 0 / 226 | 2% | 0.03 | 7 / 406 |
muscle | 1% | 1.66 | 5 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007628 | Biological process | adult walking behavior |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0055001 | Biological process | muscle cell development |
GO_1904751 | Biological process | positive regulation of protein localization to nucleolus |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0048541 | Biological process | Peyer's patch development |
GO_1901385 | Biological process | regulation of voltage-gated calcium channel activity |
GO_0007528 | Biological process | neuromuscular junction development |
GO_0048536 | Biological process | spleen development |
GO_0046058 | Biological process | cAMP metabolic process |
GO_0050908 | Biological process | detection of light stimulus involved in visual perception |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0048538 | Biological process | thymus development |
GO_0099509 | Biological process | regulation of presynaptic cytosolic calcium ion concentration |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0007214 | Biological process | gamma-aminobutyric acid signaling pathway |
GO_2000300 | Biological process | regulation of synaptic vesicle exocytosis |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0014051 | Biological process | gamma-aminobutyric acid secretion |
GO_0035249 | Biological process | synaptic transmission, glutamatergic |
GO_0019227 | Biological process | neuronal action potential propagation |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098793 | Cellular component | presynapse |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0016607 | Cellular component | nuclear speck |
GO_0005891 | Cellular component | voltage-gated calcium channel complex |
GO_0005829 | Cellular component | cytosol |
GO_0019901 | Molecular function | protein kinase binding |
GO_0099626 | Molecular function | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels |
GO_0005245 | Molecular function | voltage-gated calcium channel activity |
GO_0008331 | Molecular function | high voltage-gated calcium channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CACNB4 |
Protein name | Calcium voltage-gated channel auxiliary subunit beta 4 Voltage dependent calcium channel beta 4 subunit Voltage-dependent L-type calcium channel subunit beta-3 (Calcium channel voltage-dependent subunit beta 3) Uncharacterized protein CACNB4 Voltage-dependent L-type calcium channel subunit beta-4 (CAB4) (Calcium channel voltage-dependent subunit beta 4) |
Synonyms | CACNLB4 |
Description | FUNCTION: The beta subunit of voltage-dependent calcium channels contributes to the function of the calcium channel by increasing peak calcium current, shifting the voltage dependencies of activation and inactivation, modulating G protein inhibition and controlling the alpha-1 subunit membrane targeting. . |
Accessions | A0A1B0GTN2 A0A1B0GTP6 A0A1B0GTA9 A0A1B0GTL1 A0A1B0GUW8 A0A1B0GUJ7 ENST00000636785.1 A0A1B0GTK1 ENST00000637330.1 ENST00000636496.1 A0A1B0GVP7 A0A1B0GUK4 ENST00000637436.1 A0A1B0GVF0 ENST00000636350.1 ENST00000434468.2 A0A1B0GUM9 ENST00000636773.1 A0A1B0GW58 A0A1B0GTS4 ENST00000636390.1 ENST00000637217.1 ENST00000201943.10 [O00305-4] A0A1B0GU32 ENST00000636130.1 ENST00000534999.7 [O00305-2] A0A1B0GW81 A0A1B0GTN8 ENST00000637514.1 ENST00000636947.1 A0A1B0GU42 ENST00000637535.1 A0A1B0GTP5 A0A1B0GU05 E7DBM8 A0A1B0GTH0 E7EN11 ENST00000637232.1 ENST00000638056.1 ENST00000635738.1 A0A1B0GVT6 A0A1B0GUI5 ENST00000637007.1 Q53S65 A0A1B0GUU5 A0A1B0GVU5 ENST00000638150.1 A0A1B0GW63 ENST00000439467.6 Q9NZA2 A0A1B0GTX8 ENST00000637216.1 A0A1B0GWG5 ENST00000638005.1 [O00305-3] ENST00000637132.1 A0A1B0GUK3 ENST00000636129.1 ENST00000636598.1 ENST00000636901.1 A0A1B0GTX2 ENST00000397327.7 ENST00000637762.1 A0A1B0GU53 A0A1B0GUU8 ENST00000637284.1 ENST00000636507.1 ENST00000637309.1 ENST00000637224.1 ENST00000637491.1 H0Y476 ENST00000635890.1 A0A1B0GV16 ENST00000360283.11 ENST00000635904.1 ENST00000427385.6 ENST00000637547.1 ENST00000637559.1 A0A1B0GVB2 ENST00000637956.1 O00305 ENST00000637418.1 ENST00000638091.1 A0A1B0GWF9 A0A1B0GUI8 ENST00000636664.1 A0A1B0GTX6 ENST00000636380.1 ENST00000539935.7 [O00305-1] ENST00000636762.1 ENST00000636617.1 A0A1B0GVG1 ENST00000638040.1 Q580I4 ENST00000635930.1 ENST00000637779.1 ENST00000636442.1 ENST00000636721.1 ENST00000636108.1 ENST00000637828.1 A0A1B0GXG0 A0A1B0GTF6 A0A1B0GU07 ENST00000637550.1 A0A1C7CYX2 ENST00000637312.1 C9J224 |